DE602005022876D1 - Sterol-angereicherte multilamellare amphotericin-enthaltende liposomen in kochsalzlösung und herstellungsverfahren - Google Patents

Sterol-angereicherte multilamellare amphotericin-enthaltende liposomen in kochsalzlösung und herstellungsverfahren

Info

Publication number
DE602005022876D1
DE602005022876D1 DE602005022876T DE602005022876T DE602005022876D1 DE 602005022876 D1 DE602005022876 D1 DE 602005022876D1 DE 602005022876 T DE602005022876 T DE 602005022876T DE 602005022876 T DE602005022876 T DE 602005022876T DE 602005022876 D1 DE602005022876 D1 DE 602005022876D1
Authority
DE
Germany
Prior art keywords
amphotericin
sterol
multilamellar
enriched
manufacturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005022876T
Other languages
German (de)
English (en)
Inventor
Jitendra Nath Verma
Lily Verma
Krishan Kumar Tripathi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lifecare Innovations Pvt Ltd Gurgaon Harya In
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE602005022876D1 publication Critical patent/DE602005022876D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
DE602005022876T 2004-06-11 2005-06-13 Sterol-angereicherte multilamellare amphotericin-enthaltende liposomen in kochsalzlösung und herstellungsverfahren Expired - Lifetime DE602005022876D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1113DE2004 2004-06-11
PCT/IN2005/000193 WO2005120460A1 (en) 2004-06-11 2005-06-13 Sterol enriched mixed lammelarity amphotericin intercalating liposomes in saline and the process for their preparation

Publications (1)

Publication Number Publication Date
DE602005022876D1 true DE602005022876D1 (de) 2010-09-23

Family

ID=34972096

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005022876T Expired - Lifetime DE602005022876D1 (de) 2004-06-11 2005-06-13 Sterol-angereicherte multilamellare amphotericin-enthaltende liposomen in kochsalzlösung und herstellungsverfahren

Country Status (9)

Country Link
US (1) US20070218119A1 (cg-RX-API-DMAC7.html)
EP (1) EP1771156B8 (cg-RX-API-DMAC7.html)
JP (1) JP4966855B2 (cg-RX-API-DMAC7.html)
CN (1) CN101014322A (cg-RX-API-DMAC7.html)
AT (1) ATE476965T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005251572B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0511371A (cg-RX-API-DMAC7.html)
DE (1) DE602005022876D1 (cg-RX-API-DMAC7.html)
WO (1) WO2005120460A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1003990B1 (pt) * 2009-10-16 2021-09-14 Lifecare Innovations Pvt. Ltd Formulação para o tratamento de infecções fúngicas
CN108602025B (zh) 2016-03-04 2021-02-26 栗田工业株式会社 选择性透过膜及其制造方法、使用该选择性透过膜的水处理方法
PT3694526T (pt) 2017-10-11 2025-01-20 Univ Illinois Resgate independente do genótipo da fibrose quística com canais de bicarbonato de moléculas pequenas
IL315719A (en) 2022-03-21 2024-11-01 Univ Illinois Prosthetic assemblies of ion channels containing lipid-coated amphotericin B crystals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2134869A (en) * 1983-02-15 1984-08-22 Squibb & Sons Inc Method of preparing liposomes and products produced thereby
US4744989A (en) * 1984-02-08 1988-05-17 E. R. Squibb & Sons, Inc. Method of preparing liposomes and products produced thereby
US4766046A (en) * 1985-09-27 1988-08-23 Liposome Technology, Inc. Stabilized liposome/amphotericin composition and method

Also Published As

Publication number Publication date
EP1771156A1 (en) 2007-04-11
WO2005120460A1 (en) 2005-12-22
AU2005251572B2 (en) 2010-03-11
AU2005251572A1 (en) 2005-12-22
BRPI0511371A (pt) 2008-03-11
US20070218119A1 (en) 2007-09-20
JP2008501782A (ja) 2008-01-24
EP1771156B1 (en) 2010-08-11
CN101014322A (zh) 2007-08-08
JP4966855B2 (ja) 2012-07-04
ATE476965T1 (de) 2010-08-15
EP1771156B8 (en) 2010-09-15

Similar Documents

Publication Publication Date Title
NO20075136L (no) Nye liposompreparater
Jung et al. A fatal case of intravascular coagulation after bee sting acupuncture
CA2690111A1 (en) Anthelmintic combination
FR15C0009I2 (fr) Compositions de gel phospholipide destinees a l'administration medicamenteuse et des methodes de traitement utilisant celles-ci
WO2003000336A3 (en) Magnetic therapy devices and methods
EP1792927A4 (en) NEW BLOCK COPOLYMER, MICELLA PREPARATION AND ANTICROPHIDE CONTAINING THIS AS ACTIVE INGREDIENTS
DE60118743D1 (de) Methode zur behandlung und prävention von ansteckenden krankheiten
DE602004013993D1 (de) R für biologische wirksubstanz zur oralen verabreichung
CY1112981T1 (el) Μεθοδος και συνθεση για την αγωγη της ρινιτιδας
EP1596868A4 (en) METHOD FOR TREATING HEAVY HEART FAILURE AND MEDICAMENT THEREFOR
AR049137A1 (es) Formulacion de irinotecan en vesicula cerrada, para el tratamiento del cancer
EA200601846A1 (ru) Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей
BRPI0418157A (pt) terapêutica de tumores alogênicos
EA201300421A1 (ru) Комбинированная терапия для лечения инфекции hcv
MXPA05012392A (es) Tratamientos de ansiedad con ziprasidona.
ATE476965T1 (de) Sterol-angereicherte multilamellare amphotericin- enthaltende liposomen in kochsalzlösung und herstellungsverfahren
EA200900269A1 (ru) Лекарственные комбинации для лечения заболеваний дыхательных путей
ATE358992T1 (de) Enteralpräparat zur vorbeugung gegen bzw. behandlung von sepsis
DK1638492T3 (da) Præoperativ behandling af postoperativ smerte
EA200501252A1 (ru) Липосомальная композиция, способ ее получения и лекарственное средство на ее основе (варианты)
van den Hurk et al. Nonpegylated liposomal doxorubicin: reduction in cardiotoxicity, although still severe alopecia
WO2003028736A3 (de) Alkylphosphocholinverbindungen enthaltende arzneimittelzubereitungen in sterilfiltrierbaren und/oder hitzesterilisierbaren liposomen
Kupferschmidt 'A sigh of relief': New malaria drug succeeds in clinical trial as existing treatments falter.
RU2001100258A (ru) Способ консервативного лечения гемофтальмов различного генеза
RU2005127503A (ru) Способ лечения рецидива рака молочной железы

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: LIFECARE INNOVATIONS PVT. LTD., GURGAON, HARYA, IN